Skyhawk Therapeutics Europe AG
Skyhawk Therapeutics, with laboratories in Boston (U.S.) and the Basel Technology Park, is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. Our founders are leading experts in developing small molecule therapeutics for RNA-based disease. Our first drug candidates are targeted towards cancers and neurological conditions, some of which were previously considered undruggable.
firstname.lastname@example.org | skyhawktx.com